Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that Mollie Leoni, ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer indications - - Deal terms align shareholders' inter ...

PITTSBURGH, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, ...

The warning signs of bowel cancer everyone should know - A change in your toilet habits could be an early warning sign ...

Research shows the main ingredient in the yoghurt helps improve digestion, reduces cholesterol and possesses anti-cancer ...

For the first time, researchers have cultivated stable tumor organoids from circulating breast cancer cells, improving ...

Dorocubicel is under clinical development by ExCellThera and currently in Phase II for Blood Cancer. According to GlobalData, Phase II drugs for Blood Cancer have a 34% phase transition success rate ...

Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

A 19-year-old has shared the pre-cancer symptoms he noticed prior to being diagnosed with with stage four Hodgkin lymphoma.

Huch’s pancreatic organoids are now a promising avenue for disease modeling and generating precision medicines to treat ...

The US has been experiencing a worrying rise in cancer diagnoses, especially colorectal cancer among younger adults.

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...